Incidence of hepatitis B reactivation following Rituximab therapy

被引：44

作者：

Hanbali, Amr ^{[1
]}

Khaled, Yasser ^{[2
]}

机构：

[1] Henry Ford Hosp, Dept Med, Div Hematol Oncol, Detroit, MI 48202 USA

[2] Univ Michigan, Dept Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2009年 / 84卷 / 03期

关键词：

CHEMOTHERAPY;

D O I：

10.1002/ajh.21343

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：195 / 195

页数：1

共 4 条

[1] Late reactivation of resolved hepatitis B virus infection: An increasing complication post rituximab-based regimens treatment? [J].

Garcia-Rodriguez, Maria J. ;

Canales, Miguel A. ;

Hernandez-Maraver, Dolores ;

Hernandez-Navarro, Fernando .

AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (08) :673-675

[2] Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and rituximab despite adefovir prophylaxis [J].

Khaled, Yasser ;

Hanbali, Amr .

AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (07) :688-688

[3]

TARGHETTA C, 2008, HAEMATOLOGICA, V93

[4] Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab [J].

Yamagata, Michiko ;

Murohisa, Toshimitsu ;

Tsuchida, Kohei ;

Okamoto, Yutaka ;

Tsunoda, Saburo ;

Nakamura, Masae ;

Kusano, Koji ;

Majima, Yuichi ;

Kuniyoshi, Toru ;

Iijima, Makoto ;

Sugaya, Hitoshi ;

Hiraishi, Hideyuki .

LEUKEMIA & LYMPHOMA, 2007, 48 (02) :431-433

← 1 →